KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Operating Income: 2011-2024

Historic Operating Income for Sarepta Therapeutics (SRPT) over the last 14 years, with Dec 2024 value amounting to $218.1 million.

  • Sarepta Therapeutics' Operating Income fell 42751.07% to -$300.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$117.2 million, marking a year-over-year decrease of 408.55%. This contributed to the annual value of $218.1 million for FY2024, which is 181.43% up from last year.
  • Latest data reveals that Sarepta Therapeutics reported Operating Income of $218.1 million as of FY2024, which was up 181.43% from -$267.8 million recorded in FY2023.
  • In the past 5 years, Sarepta Therapeutics' Operating Income ranged from a high of $218.1 million in FY2024 and a low of -$564.2 million during FY2020.
  • Moreover, its 3-year median value for Operating Income was -$267.8 million (2023), whereas its average is -$195.3 million.
  • As far as peak fluctuations go, Sarepta Therapeutics' Operating Income fell by 16.64% in 2022, and later surged by 181.43% in 2024.
  • Over the past 5 years, Sarepta Therapeutics' Operating Income (Yearly) stood at -$564.2 million in 2020, then increased by 18.51% to -$459.7 million in 2021, then dropped by 16.64% to -$536.2 million in 2022, then spiked by 50.05% to -$267.8 million in 2023, then surged by 181.43% to $218.1 million in 2024.